Quantitative RT-PCR analysis of 8 tumor xenograft-derived cell lines showed that none had lost expression of either GAS6 or AXL; in fact, 6 of 8 had acquired significantly increased expression of MERTK (also activated by Gas6) and KDR (Fig 8B). The gene discussed is MERTK; the disease is neoplasm.